AHK-Cu

What it is

AHK-Cu is a copper tripeptide, meaning it is three amino acids, alanine, histidine and lysine, chemically bound to a copper ion. It is closely related to GHK-Cu, a copper tripeptide the body makes naturally, differing only in its first amino acid. That close relationship is why researchers study the two side by side, treating findings on GHK-Cu's general biology as background for what AHK-Cu might do.

The specific research interest in AHK-Cu is hair growth. Laboratory work applies it directly to human hair follicles removed and kept alive outside the body, a method called ex vivo organ culture, and to dermal papilla cells, a specialized cell type sitting where each follicle begins that helps steer the hair growth process [1]. A smaller body of work has also looked at whether copper tripeptides in general support skin-cell activity tied to collagen production and connective-tissue repair.

How it is studied

The central study method is ex vivo organ culture: human hair follicles are removed and kept alive in a dish, then exposed to AHK-Cu at very low concentrations for several days, with follicle length and dermal papilla cell counts measured under a microscope [1]. Other work looks at penetration through isolated samples of human skin to see how well a topically applied copper tripeptide moves through skin layers. None of this research involves living human volunteers using the compound over time.

What studies report

• In isolated human hair follicles kept alive in culture, AHK-Cu at very low concentrations made follicles grow longer, consistent with extending the active growth phase of that process. [1]
• In the same follicle cultures, AHK-Cu increased the count of dermal papilla cells; these sit at the follicle's base and are thought to help decide whether a hair keeps growing. [1]
• Broader review work on the related molecule GHK-Cu describes copper tripeptides shifting activity across a large number of genes tied to tissue repair, collagen production and inflammation control, work used as background for what AHK-Cu is proposed to do in skin. [2]

What is not known

No published clinical trial has tested AHK-Cu on living people, either applied to the scalp for hair or to skin for connective-tissue effects. All of the specific AHK-Cu evidence comes from isolated hair follicles and cultured cells, which do not have blood supply, immune activity, or the other systems present in living skin. It is not established whether results seen in that isolated tissue would carry over to a real scalp or skin surface, or at what concentration and delivery method.

Reported adverse findings

• The published ex vivo follicle studies did not report toxicity to the cultured tissue at the concentrations tested, but these short laboratory experiments were not designed to detect the kind of side effects a clinical safety trial would look for. [1]

Regulatory status

AHK-Cu has no approved-drug status anywhere; neither the FDA nor Health Canada has reviewed it for any medical claim. It appears in some cosmetic formulations, which in most jurisdictions face lighter regulatory review than medicines and do not require the same clinical evidence.